BPC-157 and TB-500 Dosage Protocol BPC-157: 250500mcg daily, injected subcutaneously near the injury site TB-500: 22.5mg twice weekly (loading phase) for 46 weeks, then 2mg once weekly (maintenance phase) The combination is typically used for 612 weeks, depending on injury severity and healing progress
It doesn't require a prescription, doesn't go through FDA drug approval, and cannot legally be marketed as a treatment for hair loss
All products are prepared and packaged to meet laboratory expectations, ensuring consistency, stability, and accurate compound identification
But the mechanism of GLP-1 agonists is fundamentally different from AOD 9604, and comparing them directly misses the point
Inositol is a nutrient related to the B vitamin family